NASDAQ: GALT · Biotechnology
Over the past week, Galectin Therapeutics (GALT) logged 11 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 18% bullish but is far apart: News runs 33% bullish while X sits at just 0%. Wall Street is more constructive, with 1 of 1 analysts rating GALT a buy.
There is little buzz around GALT this week and some agreement on direction, which is why it reads as a Sell.
Wall Street’s 100% buy share sits next to a crowd that ranges from X at 0% to News at 33%. No other tracker puts the two side by side.
Across 1 analysts the consensus is a Strong Buy: 1 buy call against 0 sell, with an average 12-month price target of $11.00.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 82 points above the crowd average of 18%, the professionals are more constructive than retail. The split is inside the crowd: News reads 33% bullish while X sits at 0%, a 33-point spread that single-source trackers miss.
Over the 30-day window, Galectin Therapeutics (GALT) buzz held subdued around 29.6 while the price drifted down 17.6% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 386K shares. Updated Aug 15, 2026. Over the last 7 trading days, GALT gained 6.8%. Buzz activity in the recent week averaged 20.7 and was relatively stable, swinging between 14.4 and 29.6. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 3 of the 7 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for GALT and 2000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live GALT sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 15, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (1 / 0 / 0) |
| Crowd bullish (7d) | 18% |
| Avg price target | $11.00 |
| Most bullish source | News, 33% |
| Most bearish source | X, 0% |
| Sentiment spread | 33 pts |
| Mentions (7d) | 11 |
| Market cap | $346.9M |
| P/E · Forward P/E | n/a · 4.5 |
| EPS · Beta | -$0.41 · 0.3 |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Galectin Therapeutics (GALT) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 18% bullish across 3 active sources. Those sources contribute 11 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Galectin Therapeutics (GALT) is fairly quiet with 5 mentions over the last 7 days; the 30-day context spans 3 tracked subreddits. The 7-day tone is 20% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Galectin Therapeutics (GALT), averaging 18% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 33% bullish and X at 0%, a 33-point spread. On the professional side, 1 of 1 analysts rate GALT a buy.
Of the 1 analyst covering Galectin Therapeutics (GALT), 1 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $11.00. That puts the street ahead of the crowd, which averages 18% bullish.
Galectin Therapeutics (GALT)'s cross-source average is bearish at 18% bullish. All 3 tracked sources lean bearish. Reddit reads 20% bullish, News reads 33% bullish and x coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Galectin Therapeutics (GALT) at 18% bullish. All 3 tracked sources lean bearish. The most bearish reading is x at 0% bullish. 3-day activity momentum is falling across News. The sell signal carries 93/100 conviction.
News is the dominant discussion channel with 6 mentions (55% of total volume). Reddit contributes 5 mentions. The cross-source average is bearish at 18% bullish. All 3 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. GALT's sell signal at 93/100 conviction reflects a bearish cross-source average at 18% bullish. All 3 tracked sources lean bearish. It is a research shortcut, not financial advice.
The GALT sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key